BRIEF-Biomarin provides preliminary data on first 8 patients in Hemophilia A gene therapy program By: Reuters: Company News April 20, 2016 at 08:49 AM EDT * Biomarin provides encouraging preliminary data on first 8 patients in hemophilia a gene therapy program Read More >> Related Stocks: Biomarin Pharmaceuticals